Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score.

Rogliani Paola Josuel Ora Francesco Cavalli Mario Cazzola Luigino Calzetta

Published in: Journal of clinical medicine (2022)

All triple FDCs are effective and safe in COPD regardless of the regimen of administration (twice daily vs. once daily), with no relevant difference in the risk of CV SAEs and pneumonia.

Keyphrases

chronic obstructive pulmonary disease
lung function
physical activity
cystic fibrosis
extracorporeal membrane oxygenation
acute respiratory distress syndrome
community acquired pneumonia